Tejara Capital’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDL
MI
ACM
Tejara Capital's CRDL Position: Q3 2026 in Review
Tejara Capital increased its Cardiol Therapeutics (CRDL) stake by 45% in Q3 2026, buying an estimated $3.67M and bringing the position to 7,420,429 shares worth $12.3M. The position accounts for 6.02% of the portfolio, ranked #5.
Tejara Capital first reported a position in CRDL in Q4 2022 and has held it in 16 quarters since. 43 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.
- Tejara Capital held 7,420,429 shares of Cardiol Therapeutics worth $12.3M as of Q3 2026.
- Tejara Capital bought 2,306,607 Cardiol Therapeutics shares in Q3 2026, an estimated $3.67M.
- Cardiol Therapeutics made up 6.02% of Tejara Capital's portfolio in Q3 2026, its #5 holding.
- Tejara Capital first reported a position in Cardiol Therapeutics in Q4 2022 and has held it in 16 quarters since.
- 43 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.
Based on Tejara Capital's 13F filing for Q3 2026, filed 9 Nov 2026.